Skip to main content
. 2021 Oct 29;10(21):5069. doi: 10.3390/jcm10215069

Table 1.

Patient characteristics of AS and OA controls.

AS Patients (n = 193) OA Controls (n = 74)
Patient characteristics
Gender, male (n, %) 138 (72) 43 (58)
Age, years (mean ± SD) 60 ± 7 62 ± 7
Race, Caucasian (n, %) 162 (84) 65 (88)
BMI, kg/m2 (mean ± SD) 26.6 ± 4.1 28.6 ± 5.5
BSA, m2 (mean ± SD) 1.9 ± 0.2 2.0 ± 0.2
Blood pressure, mmHg
Systolic (mean ± SD) 134 ± 16 133 ± 17
Diastolic (mean ± SD) 84 ± 8 82 ± 9
CVD risk factors
Smoking status
current (n, %) 39 (20) 15 (20)
ever (n, %) 98 (51) 35 (47)
never (n, %) 55 (29) 24 (32)
pack years (median, IQR) 28 (14–37) 12 (6–31)
Obesity (n, %) 42 (22) 26 (35)
Hypertension (n, %) 118 (61) 45 (61)
Hypercholesterolemia (n, %) 36 (19) 22 (30)
Diabetes Mellitus type II (n, %) 22 (11) 10 (14)
Total history CVD (n, %) 21 (11) 8 (11)
Angina Pectoris (n, %) 5 (3) 2 (3)
Myocardial infarction (n, %) 12 (6) 4 (5)
Stroke
TIA (n, %) 4 (2) 3 (4)
CVA (n, %) 3 (2) 0 (0)
Peripheral ischemia (n, %) 1 (1) 1 (1)
CABG (n, %) 8 (4) 2 (3)
Family history (first degree)
AP/MI (n, %) 24 (12) 11 (15)
Stroke/TIA (n, %) 14 (7) 6 (8)
Laboratory
LDL, mmol/L 3.3 ± 0.9 3.5 ± 1.1
HDL, mmol/L 1.5 ± 0.4 1.3 ± 0.4
Cholesterol/HDL ratio 3.8 ± 1.6 4.2 ± 1.7
ESR, mm/h 7.5 (4.0–10.0) 5.0 (2.0–11)
CRP, mg/L 2.8 (1.1–7.8) 1.6 (0.8–3.1)
Medication
Antihypertensives (n, %) 85 (44) 20 (27)
Lipid-modifying drugs (n, %) 40 (21) 19 (26)
NSAIDs (n, %) 108 (56) 37 (50)
Anti-TNF drugs
current (n, %) 70 (36) N.A.
ever (n, %) 13 (7) N.A.
naive (n, %) 110 (57) N.A.

Values are displayed as mean ± standard deviation (SD), median with corresponding interquartile range (IQR) or frequencies with corresponding percentages (%). AS = ankylosing spondylitis, OA = osteoarthritis, BMI = body mass index, BSA = body surface area, CVD = cardiovascular disease, TIA = transient ischemic attack, CVA = cerebrovascular attack, CABG = coronary artery bypass graft, AP = angina pectoris, MI = myocardial infarction, NSAIDs = non-steroidal anti-inflammatory drugs, anti-TNF = anti-tumor necrosis factor, N.A. = not applicable. Normal ranges for laboratory assessments: LDL 2.0–4.5 mmol/L, HDL 0.9–1.7 mmol/L, ESR in men > 50 years < 20 mm/h, ESR in women > 50 years < 30 mm/h, CRP < 10 mg/L.